Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare EMPAGLIFLOZIN (JARDIANCE) and Metformin (Glucophage) — clinical data, side effects, and patient experiences.
JARDIANCE, Jardiance, Synjardy · SGLT-2 Inhibitor
How it works
12.1 Mechanism of Action Empagliflozin is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2), the predominant transporter responsible for reabsorption of glucose from the ...
Approved for
Glucophage, Fortamet, Glumetza · Biguanide
How it works
Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Approved for
Estimated frequency (%) based on clinical trial data
Based on 30 Reddit discussions
EMPAGLIFLOZIN
20%
positive
15 threads
Metformin
27%
positive
15 threads
% of discussions mentioning each side effect
Based on 1 verified patient review
No data yet
No data yet
Avg. Duration
0 months
0% still taking
Avg. Duration
24 months
100% still taking
EMPAGLIFLOZIN is a SGLT-2 Inhibitor, while Metformin belongs to the Biguanide class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.
Metformin has an average efficacy rating of 8.0/10 and tolerability of 6.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..
EMPAGLIFLOZIN carries 4 FDA warnings. Metformin carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.